A study in Diabetes Care found that patients with breast or prostate cancer who also have type 2 diabetes face lower survival rates compared with those who do not have diabetes. Researchers also found that those who take sulfonylureas or insulin alone have a higher mortality rate and those who have metformin-only treatment have a lower mortality rate compared with patients without diabetes.
Diabetes affects survival rate in some cancer patients
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan